glp-1 agonist clinical trials Receptor Agonists as Treatments for Type 2 Diabetes The expanding role of GLP-1

These metabolic improvements not only support effective weight loss but also reduce long-term risks associated with diabetes, heart disease, and obesity-related complications

Methodology: BJ

That may not stop lawsuits, though

This may trigger irregular heartbeats, forcing the heart to work harder than usual, which can be life-threatening

[DOI] [PubMed] [Google Scholar] 459.Hothersall J.D., Brown A.J., Dale I., Rawlins P

Data and code availability All data sourced from the FinnGen consortium (R9) ( Psychiatric Genomics Consortium (PGC, and UK Biobank ( All codes are available from the corresponding author through reasonable request